Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravir (Q36553976)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 September 2012
edit
Language Label Description Also known as
English
Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravir
scientific article published on 24 September 2012

    Statements

    Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravir (English)
    Esteban Martínez
    Polyana M d'Albuquerque
    Ignacio Pérez
    Judit Pich
    José M Gatell
    24 September 2012
    235-241

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit